The Discounted Cash Flow (DCF) valuation of ACADIA Pharmaceuticals Inc (ACAD) is 31.83 USD. With the latest stock price at 22.12 USD, the upside of ACADIA Pharmaceuticals Inc based on DCF is 43.9%.
Based on the latest price of 22.12 USD and our DCF valuation, ACADIA Pharmaceuticals Inc (ACAD) is a buy. buying Acadia stocks now will result in a potential gain of 43.9%.
| Range | Selected | |
| WACC / Discount Rate | 7.9% - 9.4% | 8.7% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 25.90 - 41.96 | 31.83 |
| Upside | 17.1% - 89.7% | 43.9% |